Date | Subject | Author | Discuss |
---|
24/11/2022 09:54:55 | Where the link for 18% reduction for next year ? |  igoe104 | |
24/11/2022 09:27:57 | Agree Dr B..
toswas I hadn't seen that they were reducing 2023 numbers. |  edmundshaw | |
24/11/2022 08:59:55 | I get a bit fed up with companies saying orders retimed/reprogrammed into next year. It’s a miss. Otherwise the target should be 540m for next year.
Having said that, if they can deliver £14m next year(2.8*500m) then the shares are cheap with a 50m mkt cap |  dr biotech | |
24/11/2022 08:41:24 | Agree with most of that edmund but not just a timing issue when the house broker is reducing numbers by 11% this year and 18.5% next! |  tiswas | |
24/11/2022 08:18:51 | In reality its a big profit warning IMO. Its all down to personal opinion whether its in the price or not. |  spooky | |
24/11/2022 08:17:11 | Took my numbers from Stockopedia. Will revert to Cenkos numbers. However business is in good shape with a decent yield imo |  aishah | |
24/11/2022 08:13:43 | FY 23 eps forecast down 18.5% from 24.2p to 19.7p |  phar lap | |
24/11/2022 08:13:07 | No idea where you get your numbers from Aishah. Cenkos forecasting adjusted eps of 19p for '22, down 11%. |  tiswas | |
24/11/2022 08:07:27 | The ONLY thing the market seems to be seeing is the:- with some £40m of revenue previously expected to be delivered in 2022 now being reprogrammed into 2023... comment.
Ho hum... |  cwa1 | |
24/11/2022 07:57:12 | Snippet from Cenkos research this morning:-
◼ View: The group remains in a very strong position, targeting a balanced and protected order and a balance sheet supportive of its growth ambitions. On revised forecasts, the shares remain inexpensive on a FY23E PE of c.6x and EV/EBITDA of c.3x. With a 4.5% dividend yield and an improving balance sheet providing a further underpin to the equity story, we reiterate our BUY recommendation. |  cwa1 | |
24/11/2022 07:54:01 | EPS fcst of 25.65p though with the 27% uplift. Analyst consensus was 21.2p |  aishah | |
24/11/2022 07:23:38 | The trouble is that they were expecting £450m for 2022 and £500m for 2023, but £40m has moved into 2023, leaving 2022 at £410m and 2023 the same. Looks like EBIT will be £1m less than forecasts |  18bt | |
24/11/2022 07:19:36 | Confident trading update: "2022 is expected to be the first time Group revenues have exceeded £400 million. Operating margins (EBIT) are anticipated to be circa 2.8%.
As a result of this strong performance, the Group's earnings per share are expected to rise by approximately 27% in 2022 when compared to the prior year.
The Group remains on track to deliver £500m revenues in 2023."
"We are currently tendering in excess of £1bn of opportunities and are expecting decisions on approximately £500m of tendered projects by early 2023." |  aishah | |
02/11/2022 11:44:26 | Not a fan of low margin contractor businesses, but this is a well run outfit with good discipline on contract negotiation/pricing risk.
52m M.cap, low PE and supporting positive outlook statements. Looking attractive IMO |  owenski | |
23/9/2022 14:13:09 | Interesting the 5k I added this morning showed as a sell, and the next 2.5k bought about half an hour ago not showing yet Looks like I am not the only 'Bargain Hunter' here :) |  santangello | |
23/9/2022 14:10:00 | Interesting .....the 5k I stole this morning showed as a sell, and the 2.5k bought not long ago, not showing at all.Looks like I am not the only 'Bargain Hunter' here :) |  santangello | |
23/9/2022 13:29:04 | Couldn't resist 10k at these levels......currently xd which doesn't help at the mo (but div paid next Friday), but looking way oversold/marked down i.m.h.o |  santangello | |
01/9/2022 08:45:25 | Crikey, someone doesn't want the dividend.......there are investors like that, so no drama.
I will watch trades and add accordingly today......at a September Sale price :) |  santangello | |
12/8/2022 11:15:20 | In here now. I think even in recession many of TCO’s projects will get the go ahead. So figures look great barring economic meltdown. |  rabiddog | |
12/8/2022 11:10:53 | CTO featured on IC Alpha report 11th August, good writeup. I also saw them at Mello earlier this year. Seems like a steady business. |  hunsen | |
09/8/2022 07:22:14 | mrnumpty ----yes slow ... painful at times |  janeann | |
09/8/2022 05:34:42 | Janeann . I agree with you about the information on Hargreaves Lansdown regarding shares . Whilst realising that they can’t provide sophisticated levels of information , I find that what they do supply is too often patchy and unreliable which , given that they are , I believe , is the U.K.’s largest client broker , isn’t very impressive . On the subject of Hargreaves Lansdown , does anyone else here find their site very slow ? |  mrnumpty | |
08/8/2022 10:50:48 | Interactive Investor quote CTO 165p/169p a few mins ago. |  standish11 | |
06/8/2022 20:45:01 | I think August is a poor month for liquidity. I suspect that spread will narrow as we come out of the holiday season. Not really a trading stock at the best of times CTO. |  thorpematt | |